Webcast CME

Series Activities

Series Menu


Visit Virtual Exhibit Hall

Medical Dermatology Therapy Update



Non-Melanoma Skin Cancer

Print this Content

Release Date: July 7, 2021
Expiration Date: July 6, 2023

Estimated Time of Completion: 45 minutes

Description

Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic diseases.

The Non-Melanoma Skin Cancer adaptive learning module will review identification, diagnosis, and management for patients with non-melanoma skin cancer. Adaptive learning is a unique opportunity to truly engage in education that is more inclusive and designed for the unique learners. Be sure to participate in all five adaptive learning cases that are a part of this educational series, as you will have a custom experience with each one.

Learning Objectives

  1. Describe the pathogenesis of basal cell carcinoma.
  2. Describe the mechanism of action and side effects of vismodegib and sonidegib.
  3. Review indications for FDA approved hedgehog inhibitors and immunotherapy for skin cancer.
  4. Describe and be familiar with patient counseling with vismodegib.
  5. Review FDA approved systemic agents to treat cutaneous squamous cell carcinoma.

Target Audience

These activities are directed to physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Allison Vidimos, MD
Chair, Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:


Anthony P. Fernandez, MD, PhD
  AbbVie Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
  Celgene Corporation Consulting
  Corbus Pharmaceuticals Research / Independent Contractor
  Mallinckrodt Inc. Consulting
Research / Independent Contractor
Teaching and Speaking
  Novartis Consulting
Research / Independent Contractor
Teaching and Speaking
  Pfizer, Inc. Research / Independent Contractor
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
  UCB Consulting

The following faculty has indicated she has no relationship which, in the context of her presentation(s), could be perceived as a potential conflict of interest:

Allison Vidimos, MD


Acknowledgment

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation


Upon clicking the button below, you will be directed to either login to your Cleveland Clinic myCME account or create one, and then proceed to the adaptive learning platform.

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Dermatology and Plastic Surgery Institute.